News25/Ratings4
Price$20.31-8.22 (-28.81%)
2026-01-202026-04-23
News · 26 weeks51-90%
2025-10-262026-04-19
Mix3190d
- Insider21(68%)
- SEC Filings5(16%)
- Earnings3(10%)
- Other2(6%)
Latest news
25 items- PRClaritev Corporation Announces First Quarter 2026 Earnings Conference CallClaritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its first quarter fiscal year 2026 financial results prior to market open on Thursday, May 7, 2026, and hold a conference call at 8:00 am Eastern Time. A live webcast of the conference call can be accessed through the Investor Relations section of the Company's website at investors.claritev.com/events-and-presentations. Participants should join the webcast ten minutes prior to the start of the conference call. The earnings press release and supplemental slide deck
- INSIDERSEC Form 4 filed by Albinson Brock4 - Claritev Corp (0001793229) (Issuer)
- SECSEC Form DEFA14A filed by Claritev CorporationDEFA14A - Claritev Corp (0001793229) (Filer)
- SECSEC Form DEF 14A filed by Claritev CorporationDEF 14A - Claritev Corp (0001793229) (Filer)
- SECClaritev Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Claritev Corp (0001793229) (Filer)
- INSIDEREVP&CFO Garis Douglas Michael bought $22,997 worth of shares (1,300 units at $17.69), increasing direct ownership by 0.63% to 206,152 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- INSIDEREVP, Chief Digital Officer Kim Michael bought $247,500 worth of shares (15,000 units at $16.50), increasing direct ownership by 9% to 182,878 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- PRClaritev Corporation Announces Participation in Upcoming EventsClaritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that members of its management team will meet with investors at the following investor events in March 2026: Mizuho Virtual Healthcare Technology Conference 2026 – Thursday, March 5, 2026 - 1x1 meetings hosted virtually Q&A Webcast Hosted by Nephron Research – Friday, March 6, 2026 at 11 a.m. ET. (Webcast details below) Barclays 28th Annual Global Healthcare Conference – Wednesday, March 11, 2025, at the Loews Miami Beach Hotel, Miami Beach, FL - 1x1 meetings To listen to the Q&A we
- INSIDERSVP, General Counsel O'Neil Tara covered exercise/tax liability with 2,216 shares and was granted 18,130 shares, increasing direct ownership by 59% to 43,113 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- INSIDERDirector White Dale A. covered exercise/tax liability with 14,158 shares, decreasing direct ownership by 9% to 145,922 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- INSIDEREVP&CFO Garis Douglas Michael covered exercise/tax liability with 5,331 shares and was granted 66,322 shares, increasing direct ownership by 42% to 204,852 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- INSIDEREVP, Chief Digital Officer Kim Michael covered exercise/tax liability with 4,582 shares and was granted 34,487 shares, increasing direct ownership by 22% to 167,878 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- INSIDEREVP, Chief Operating Officer Hogge Jerome covered exercise/tax liability with 4,800 shares and was granted 66,322 shares, increasing direct ownership by 62% to 160,268 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- INSIDERSVP, Chief Strategy Officer Mintz William B. covered exercise/tax liability with 1,137 shares and was granted 19,060 shares, increasing direct ownership by 27% to 83,248 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- INSIDERSVP, Chief Accounting Officer Albinson Brock was granted 23,243 shares, increasing direct ownership by 582% to 27,237 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- INSIDERSVP, Chief Growth Officer Misencik Tiffani was granted 26,342 shares and covered exercise/tax liability with 1,660 shares, increasing direct ownership by 23% to 132,573 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- INSIDERSVP, Chief People Officer Carol Nutter covered exercise/tax liability with 2,812 shares and was granted 18,130 shares, increasing direct ownership by 50% to 46,066 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- INSIDERPres., CEO & Executive Chair Dalton Travis covered exercise/tax liability with 23,630 shares and was granted 278,925 shares, increasing direct ownership by 105% to 498,353 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- PRClaritev Corporation To Host 2026 Investor DayClaritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, will host its 2026 Investor Day on Monday, March 16, 2026 at the New York Stock Exchange. The event will feature presentations by members of Claritev's management team discussing the company's long term growth strategy, vertical markets, product roadmap, and financial outlook, along with conversations with a number of clients and partners. The event and a live webcast will begin at 1:00 p.m. ET. Registration for the webcast can be found at https://www.claritev.com/investor-day-2026/. An archive of the webcast wi
- INSIDEREVP, Chief Digital Officer Kim Michael bought $428,955 worth of shares (30,000 units at $14.30), increasing direct ownership by 28% to 137,973 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- INSIDERPres., CEO & Executive Chair Dalton Travis bought $199,928 worth of shares (15,380 units at $13.00) (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- INSIDERSVP, General Counsel O'Neil Tara bought $9,742 worth of shares (750 units at $12.99), increasing direct ownership by 3% to 27,199 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- SECSEC Form 10-K filed by Claritev Corporation10-K - Claritev Corp (0001793229) (Filer)
- SECClaritev Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits8-K - Claritev Corp (0001793229) (Filer)
- PRClaritev Corporation Reports Fourth Quarter and Full Year 2025 ResultsQ4 2025 Revenues of $246.6 million, Net loss of $80.6 million, and Adjusted EBITDA of $151.3 million (Adjusted EBITDA Margin of 61.4%) Full-year 2025 Revenues of $965.4 million (increase of 3.7% compared to FY 2024), Net loss of $284.3 million, and Adjusted EBITDA of $602.6 million (increase of 4.5% compared to FY 2024) Full-year 2026 Guidance initiated: Revenue range of $980 million to $1 billion Free cash flow of $0 million to $10 million Capital expenditures of $160 million to $170 million Company Board of Directors approves $75 million, five-year share repurchase program Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insigh